Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder

BACKGROUND: One third of patients with major depressive disorder (MDD) fail to respond to currently available antidepressant medications. Inflammation may contribute to treatment non-response through effects on neurotransmitter systems relevant to antidepressant efficacy. In post-hoc analyses, incre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Psychoneuroendocrinology
Autors principals: Haroon, Ebrahim, Daguanno, Alexander W., Woolwine, Bobbi J., Goldsmith, David R., Baer, Wendy M., Wommack, Evanthia C., Felger, Jennifer C., Miller, Andrew H.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6427066/
https://ncbi.nlm.nih.gov/pubmed/29800779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.psyneuen.2018.05.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars